CATALOGO DEI PRODOTTI DELLA RICERCA

FRACASSO, Giulio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.459
EU - Europa 3.050
AS - Asia 1.174
SA - Sud America 25
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 7.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.414
GB - Regno Unito 1.178
CN - Cina 878
IT - Italia 314
SE - Svezia 303
IE - Irlanda 292
FR - Francia 272
FI - Finlandia 184
DE - Germania 178
RU - Federazione Russa 166
SG - Singapore 108
UA - Ucraina 68
VN - Vietnam 51
KR - Corea 36
CA - Canada 32
BE - Belgio 29
TR - Turchia 27
JP - Giappone 15
PL - Polonia 14
IN - India 13
IR - Iran 13
BR - Brasile 11
MX - Messico 11
NL - Olanda 8
ES - Italia 5
PH - Filippine 5
PT - Portogallo 5
AR - Argentina 4
CH - Svizzera 4
EC - Ecuador 4
LV - Lettonia 4
AU - Australia 3
AZ - Azerbaigian 3
BY - Bielorussia 3
CL - Cile 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HK - Hong Kong 3
ID - Indonesia 3
LU - Lussemburgo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CM - Camerun 2
HR - Croazia 2
KW - Kuwait 2
MA - Marocco 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
BG - Bulgaria 1
BT - Bhutan 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 7.721
Salva come PNG Salva come JPEG
Città #
Southend 1.073
Chandler 644
Jacksonville 563
Woodbridge 408
Dublin 289
Ann Arbor 281
Houston 203
Beijing 180
Ashburn 167
Verona 134
Lawrence 106
Princeton 106
Wilmington 100
Jinan 88
Nanjing 76
Singapore 69
Shenyang 64
New York 52
Hebei 49
Tianjin 45
Changsha 41
Sindelfingen 39
Dong Ket 35
Helsinki 33
Zhengzhou 33
Seoul 31
Brussels 29
Boardman 26
Seattle 26
Haikou 25
Ningbo 25
Milan 23
Redwood City 23
Hangzhou 22
Jiaxing 22
Taiyuan 21
Taizhou 21
Nanchang 19
Norwalk 18
Guangzhou 17
Lancaster 17
Fuzhou 16
Redmond 14
Los Angeles 13
Montréal 13
Tokyo 13
Warsaw 12
Bologna 11
San Francisco 11
Padova 9
Paris 8
Kent 7
Lanzhou 7
Phoenix 7
Tehran 7
Elora 5
Salt Lake City 5
Washington 5
Auburn Hills 4
Chicago 4
Dongguan 4
Fairfield 4
Guayaquil 4
Kemerovo 4
Leawood 4
London 4
Tappahannock 4
Toronto 4
Ardabil 3
Baku 3
Belluno 3
Cambridge 3
Chions 3
Dearborn 3
Düsseldorf 3
Edinburgh 3
Falls Church 3
Kochi 3
Luxembourg 3
Menlo Park 3
Montreal 3
Mumbai 3
Ome 3
Puxian 3
Riga 3
Salerno 3
Sejong 3
Shanghai 3
Trieste 3
Windsor 3
Almere Stad 2
Amsterdam 2
Augusta 2
Bari 2
Boston 2
Boydton 2
Bratislava 2
Buenos Aires 2
Cutrofiano 2
Dallas 2
Totale 5.532
Salva come PNG Salva come JPEG
Nome #
Anti PSMA immunotoxins activity against prostate cancer cell lines. 123
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 123
Filamin A-mediated interaction of Prostate Specific Membrane Antigen (PSMA) with beta1 integrin regulates survival of advanced prostate cancer cells 114
Cooperation of Prostate Specific Membrane Antigen with beta 1 integrin promotes the survival of aggressive prostate cancer cells 114
Immunotoxins and other conjugates: preparation and general characteristics. 112
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 107
Anti-PSMA-Immunotoxins: a new therapeutical strategy for selective targeting of toxins to prostate cancer cells. 104
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 103
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 101
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 100
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia 100
Reductive activation of ricin and ricin-A chain immunotoxins by Protein Disulfide Isomerase and Thioredoxin Reductase system. 99
N-terminal deletion affetcs catalytic activity of saporin toxin. 99
Protein Disulfide Isomerase and Thioredoxin Reductase: a ricin disulfide reducing system in the endoplasmic reticulum. 98
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 98
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 98
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 98
Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor-Associated Antigens 98
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 97
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 97
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 96
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 95
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 94
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 92
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 92
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. 91
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 91
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection 89
Prostate-specific membrane antigen associates already in the endoplasmic reticulum with lipid microdomains 89
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 88
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 87
Effect of therapeutic macromolecules in spheroids 86
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 85
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 85
Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation 85
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 85
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures 85
Prostate-specific membrane antigen (PSMA) associates early in the endoplasmic reticulum with lipid microdomains 84
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 84
Targeting human prostate cancer with (111) In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. 83
Biodistribution of In-111-labeled D2B IgG, F(ab’)2 and Fab fragments in nude mice bearing human prostate cancer xenografts 83
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 82
Discriminatory role of detergent-resistant membranes in the dimerization and endocytosis of prostate-specific membrane antigen 81
Targeted Killing of Prostate Cancer Cells using Antibody-Drug conjugated Carbon Nanohorns 81
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 80
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 79
Gangliosides act as onconeural antigens in paraneoplastic neuropathies. 78
Magneto-Plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging 75
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models 75
Laser generated gold nanocorals with broadband plasmon absorption for photothermal applications 75
Liposomes derivatized with multimeric copies of KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells 75
The Filamin A-mediated cooperation of Prostate Specific Membrane Antigen (PSMA) with beta1 integrin promotes the survival of aggressive prostate cancer cells. 74
Highly sensitive electrochemiluminescence detection of a prostate cancer biomarker 74
Pharmacokinetics of intrathecal transferrin-ricin A chain immunotoxins 73
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin 73
Cloning and characterisation of canine prostate-specific membrane antigen 73
Prostate Specific Membrane Antigen (PSMA) associates with Filamin A, beta1 integrin, pp130CAS and pSrc thus regulating the activation of beta1 integrin and the survival of prostate cancer cells. 73
Pegylated silica nanoparticles: cytotoxicity and macrophage uptake 73
Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model 72
An electrochemiluminescent-supramolecular approach to sarcosine detection for early diagnosis of prostate cancer. 71
null 70
Improved method for carbohydrate-deficient transferrin determination in human serum by capillary zone electrophoresis 69
Characterization of an In-111-labeled anti-PSMA antibody-photosensitizer conjugate for targeted photodynamic therapy of PSMA-expressing tumors 69
Prostate-specific membrane antigen routing to the cell surface implicates an early association step in the endoplasmic reticulum with lipid microdomains. 67
In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe 67
SERS IMAGING OF CANCER CELLS WITH ANTIBODY FUNCTIONALIZED GOLD NANOPARTICLES 66
null 61
Targeted Silica Nanoparticles for PhotoDynamic Therapy (PDT) 61
Acute sarcomeric M-Line Disease associated with ATP synthase subunit α autoantibodies in ankylosing spondylitis 61
Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA) 60
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors 60
Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer 60
Characterization of In-111-labeled site-specifically conjugated anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors 59
Design and Evaluation of 223Ra-Labeled and Anti-{PSMA} Targeted {NaA} Nanozeolites for Prostate Cancer Therapy{ extemdash}Part {II}. Toxicity, Pharmacokinetics and Biodistribution 59
Different Glycoforms of Prostate-Specific Membrane Antigen are intracellularly transported through their Association with Distinct Detergent-Resistant Membranes 57
Efficient AuFeOx Nanoclusters of Laser-Ablated Nanoparticles in Water for Cells Guiding and Surface-Enhanced Resonance Raman Scattering Imaging 56
SERS labels for quantitative assays: application to the quantification of gold nanoparticles uptaken by macrophage cells 54
Safe Core-Satellite Magneto-Plasmonic Nanostructures for Efficient Targeting and Photothermal Treatment of Tumor Cells 53
Ribosome-inactivating protein-containing conjugates for therapeutic use 52
The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in vivo biodistribution and mitoxantrone encapsulation homogeneity 52
Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness 51
Simple and Rapid Non-Enzymatic Procedure Allows the Isolation of Structurally Preserved Connective Tissue Micro-Fragments Enriched with SVF 51
Immunology of RIPs and their Immunotoxins, in Ribosome-inactivating Proteins: Ricin and Related Proteins 50
Improved doxorubicin encapsulation and pharmacokinetics of ferritin-fusion protein nanocarriers bearing proline, serine, and alanine elements 50
Polymer-coated silver-iron nanoparticles as efficient and biodegradable MRI contrast agents 49
Mitoxantrone-loaded nanoferritin slows tumor growth and improves the overall survival rate in a subcutaneous pancreatic cancer mouse model 49
Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen 48
SERRS Multiplexing with Multivalent Nanostructures for the Identification and Enumeration of Epithelial and Mesenchymal Cells 48
New Tc-99m-radioimmunoconjugates for pancreatic carcinoma detection 47
Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma 46
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 45
Dual modality imaging of PSMA-expressing prostate cancer with a new radiolabeled anti-PSMA monoclonal antibody conjugated with IRDye800CW 45
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors 45
Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging 44
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 44
Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy 44
Dual-modality image-guided surgery of prostate cancer with a radiolabeled fluorescent anti-PSMA monoclonal antibody 43
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 43
Design and Evaluation of 223Ra-Labeled and Anti-{PSMA} Targeted {NaA} Nanozeolites for Prostate Cancer Therapy{ extendash}Part I 42
D2B antibody and its scFvD2B fragment in nanomedicine: promising tools in the theranostics of prostate cancer 42
Totale 7.508
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.104
article - articoli 19.173
book - libri 0
conference - conferenze 6.037
curatela - curatele 0
other - altro 0
patent - brevetti 471
selected - selezionate 0
volume - volumi 423
Totale 52.208
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020764 0 5 3 82 96 100 94 57 40 93 68 126
2020/2021905 68 145 61 95 113 101 21 66 52 20 97 66
2021/2022884 79 250 14 81 37 18 16 51 20 33 74 211
2022/20231.892 147 181 171 322 136 457 74 130 200 13 46 15
2023/2024898 43 85 91 94 109 122 35 55 12 79 123 50
2024/2025190 113 77 0 0 0 0 0 0 0 0 0 0
Totale 7.832